Angiogenic protection from focal ischemia with angiotensin II type 1 receptor blockade in the rat
- 1 April 2005
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 288 (4), H1989-H1996
- https://doi.org/10.1152/ajpheart.00839.2004
Abstract
Angiogenesis within an ischemic region of the brain may increase tissue viability and act to limit the extent of an infarct. The ANG II pathway can both stimulate and inhibit angiogenesis depending on the tissue and the activated receptors. Previous work showed that 2-wk losartan administration (ANG II type 1 receptor blockade) initiates a significant cerebral angiogenic response. We hypothesized that administration of losartan in the drinking water of rats for 2 wk before initiation of focal ischemia would decrease the extent of the resulting infarct. Adult male Sprague-Dawley rats were given losartan (50 mg/day) in drinking water for 2 wk before initiation of cerebral focal ischemia produced by cauterization of cortical surface vessels. Controls received normal drinking water. In control animals, three main vessels feeding the whisker barrel cortex were cauterized, resulting in cessation of blood flow. The same protocol was followed for losartan-treated animals but did not result in cessation of blood flow in the whisker barrel cortex. Another group of losartan-treated animals received between 8 and 14 cauterizations of surface vessels feeding the whisker barrel cortex, and cessation of blood flow was verified. Rats were killed 72 h after surgery. Morphological examination revealed angiogenesis, maintained vascular delivery, and significantly decreased infarct size in losartan-treated animals compared with controls. These results demonstrate that pretreatment with losartan reduces infarct size after cerebral focal ischemia and support the hypothesis that cerebral angiogenesis may be one of the mechanisms responsible.This publication has 27 references indexed in Scilit:
- Metabolic changes of arachidonic acid after cerebral ischemia–reperfusion in diabetic ratsExperimental Neurology, 2003
- Protection Against Ischemia and Improvement of Cerebral Blood Flow in Genetically Hypertensive Rats by Chronic Pretreatment With an Angiotensin II AT 1 AntagonistStroke, 2002
- Angiotensin II AT 1 Blockade Normalizes Cerebrovascular Autoregulation and Reduces Cerebral Ischemia in Spontaneously Hypertensive RatsStroke, 2000
- Blockade of Central Angiotensin AT 1 Receptors Improves Neurological Outcome and Reduces Expression of AP-1 Transcription Factors After Focal Brain Ischemia in RatsStroke, 1999
- Cardiac and Vascular Effects of Long-term Losartan Treatment in Stroke-Prone Spontaneously Hypertensive RatsHypertension, 1996
- Opposing Actions of Angiotensin II on Microvascular Growth and Arterial Blood PressureHypertension, 1996
- Ministrokes in Rat Barrel CortexStroke, 1995
- Role of angiogenesis in patients with cerebral ischemic stroke.Stroke, 1994
- Angiotensin II decreases mortality rate in gerbils with unilateral carotid ligation.Stroke, 1986
- Effects of angiotensin II and angiotensin II antagonist saralasin on cell growth and renin in 3T3 and SV3T3 cellsJournal of Cellular Physiology, 1979